430 related articles for article (PubMed ID: 9588746)
1. Polymorphisms of HLA class II genes and autoimmune responses to Ro/SS-A-La/SS-B among Japanese subjects.
Miyagawa S; Shinohara K; Nakajima M; Kidoguchi K; Fujita T; Fukumoto T; Yoshioka A; Dohi K; Shirai T
Arthritis Rheum; 1998 May; 41(5):927-34. PubMed ID: 9588746
[TBL] [Abstract][Full Text] [Related]
2. Neonatal lupus erythematosus: studies on HLA class II genes and autoantibody profiles in Japanese mothers.
Miyagawa S; Shinohara K; Kidoguchi K; Fujita T; Fukumoto T; Hashimoto K; Yoshioka A; Shirai T
Autoimmunity; 1997; 26(2):95-101. PubMed ID: 9546818
[TBL] [Abstract][Full Text] [Related]
3. HLA markers and clinical characteristics in Caucasians with primary Sjögren's syndrome.
Bolstad AI; Wassmuth R; Haga HJ; Jonsson R
J Rheumatol; 2001 Jul; 28(7):1554-62. PubMed ID: 11469461
[TBL] [Abstract][Full Text] [Related]
4. Specific amino acid residues in the second hypervariable region of HLA-DQA1 and DQB1 chain genes promote the Ro (SS-A)/La (SS-B) autoantibody responses.
Reveille JD; Macleod MJ; Whittington K; Arnett FC
J Immunol; 1991 Jun; 146(11):3871-6. PubMed ID: 2033256
[TBL] [Abstract][Full Text] [Related]
5. Association of increased frequencies of HLA-DPB1*05:01 with the presence of anti-Ro/SS-A and anti-La/SS-B antibodies in Japanese rheumatoid arthritis and systemic lupus erythematosus patients.
Furukawa H; Oka S; Shimada K; Sugii S; Hashimoto A; Komiya A; Fukui N; Nagai T; Hirohata S; Setoguchi K; Okamoto A; Chiba N; Suematsu E; Miyashita T; Migita K; Suda A; Nagaoka S; Tsuchiya N; Tohma S
PLoS One; 2013; 8(1):e53910. PubMed ID: 23320107
[TBL] [Abstract][Full Text] [Related]
6. Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): a European multicentre study.
Tzioufas AG; Wassmuth R; Dafni UG; Guialis A; Haga HJ; Isenberg DA; Jonsson R; Kalden JR; Kiener H; Sakarellos C; Smolen JS; Sutcliffe N; Vitali C; Yiannaki E; Moutsopoulos HM
Ann Rheum Dis; 2002 May; 61(5):398-404. PubMed ID: 11959762
[TBL] [Abstract][Full Text] [Related]
7. Associations of MHC class II alleles in Norwegian primary Sjögren's syndrome patients: implications for development of autoantibodies to the Ro52 autoantigen.
Nakken B; Jonsson R; Brokstad KA; Omholt K; Nerland AH; Haga HJ; Halse AK
Scand J Immunol; 2001 Oct; 54(4):428-33. PubMed ID: 11555411
[TBL] [Abstract][Full Text] [Related]
8. The contribution of HLA-DQB1 coding and QBP promoter alleles to anti-Ro alone autoantibody response in systemic lupus erythematosus.
Logar D; Vidan-Jeras B; Dolzan V; Bozic B; Kveder T
Rheumatology (Oxford); 2002 Mar; 41(3):305-11. PubMed ID: 11934968
[TBL] [Abstract][Full Text] [Related]
9. HLA class II phenotype controls diversification of the autoantibody response in primary Sjögren's syndrome (pSS).
Rischmueller M; Lester S; Chen Z; Champion G; Van Den Berg R; Beer R; Coates T; McCluskey J; Gordon T
Clin Exp Immunol; 1998 Feb; 111(2):365-71. PubMed ID: 9486405
[TBL] [Abstract][Full Text] [Related]
10. Distributions of HLA class II alleles in autoantibody subsets among Norwegian patients with systemic lupus erythematosus.
Skarsvåg S; Hansen KE; Moen T; Eggen BM
Scand J Immunol; 1995 Nov; 42(5):564-71. PubMed ID: 7481563
[TBL] [Abstract][Full Text] [Related]
11. Primary Sjögren's syndrome: role of the HLA-DRB1*0301-*1501 heterozygotes.
Guggenbuhl P; Jean S; Jego P; Grosbois B; Chalès G; Semana G; Lancien G; Veillard E; Pawlotsky Y; Perdriger A
J Rheumatol; 1998 May; 25(5):900-5. PubMed ID: 9598888
[TBL] [Abstract][Full Text] [Related]
12. Association of the TAP2*Bky2 allele with presence of SS-A/Ro and other autoantibodies in Japanese patients with systemic lupus erythematosus.
Kanagawa S; Morinobu A; Koshiba M; Kageyama G; Hayashi N; Yoshino S; Tokano Y; Hashimoto H; Kumagai S
Lupus; 2003; 12(4):258-65. PubMed ID: 12729048
[TBL] [Abstract][Full Text] [Related]
13. The immunogenetic relationship between anti-Ro(SS-A)/La(SS-B) antibody positive Sjögren's/lupus erythematosus overlap syndrome and the neonatal lupus syndrome.
Alexander EL; McNicholl J; Watson RM; Bias W; Reichlin M; Provost TT
J Invest Dermatol; 1989 Dec; 93(6):751-6. PubMed ID: 2584740
[TBL] [Abstract][Full Text] [Related]
14. In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response.
Gottenberg JE; Busson M; Loiseau P; Cohen-Solal J; Lepage V; Charron D; Sibilia J; Mariette X
Arthritis Rheum; 2003 Aug; 48(8):2240-5. PubMed ID: 12905478
[TBL] [Abstract][Full Text] [Related]
15. Comparison of HLA class II genes in Caucasoid, Chinese, and Japanese patients with primary Sjögren's syndrome.
Kang HI; Fei HM; Saito I; Sawada S; Chen SL; Yi D; Chan E; Peebles C; Bugawan TL; Erlich HA
J Immunol; 1993 Apr; 150(8 Pt 1):3615-23. PubMed ID: 8468491
[TBL] [Abstract][Full Text] [Related]
16. Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome.
Harley JB; Alexander EL; Bias WB; Fox OF; Provost TT; Reichlin M; Yamagata H; Arnett FC
Arthritis Rheum; 1986 Feb; 29(2):196-206. PubMed ID: 3485431
[TBL] [Abstract][Full Text] [Related]
17. Clinical, serological, and HLA phenotype subsets in Sjögren's syndrome.
Pease CT; Shattles W; Charles PJ; Venables PJ; Maini RN
Clin Exp Rheumatol; 1989; 7(2):185-90. PubMed ID: 2786788
[TBL] [Abstract][Full Text] [Related]
18. Specific HLA-DQA and HLA-DRB1 alleles confer susceptibility to Sjögren's syndrome and autoantibody production.
Fei HM; Kang H; Scharf S; Erlich H; Peebles C; Fox R
J Clin Lab Anal; 1991; 5(6):382-91. PubMed ID: 1685512
[TBL] [Abstract][Full Text] [Related]
19. Autoantibody responses to the "native" 52-kDa SS-A/Ro protein in neonatal lupus syndromes, systemic lupus erythematosus, and Sjogren's syndrome.
Buyon JP; Slade SG; Reveille JD; Hamel JC; Chan EK
J Immunol; 1994 Apr; 152(7):3675-84. PubMed ID: 7511655
[TBL] [Abstract][Full Text] [Related]
20. HLA class II influences the immune response and antibody diversification to Ro60/Sjögren's syndrome-A: heightened antibody responses and epitope spreading in mice expressing HLA-DR molecules.
Paisansinsup T; Deshmukh US; Chowdhary VR; Luthra HS; Fu SM; David CS
J Immunol; 2002 Jun; 168(11):5876-84. PubMed ID: 12023392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
